Resistance against broad-spectrum β-lactams among uropathogens in children

Pediatric Nephrology

Volumn 24, Issue 12, 2009, Pages 2381-2386

  Bitsori, Maria ^a   Maraki, Sofia ^a   Kalmanti, Maria ^a   Galanakis, Emmanouil ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

lactams; Broad spectrum; Extended spectrum lactamases; Resistance; Uropathogens

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE AMPC; CARBAPENEM; CEFOXITIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; ENTEROBACTERIACEAE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; FEMALE; GREECE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 70350674355     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1255-1     Document Type: Article

References (38)

1. Knothe H, Shah P, Kremery V, Antal M, Mitsuhashi S (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315-317
2. Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K (1989) Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 33:1451-1456
3. Jacoby GA (1997) Extended-spectrum beta-lactamases and other enzymes providing resistance to oxymino-beta-lactams. Infect Dis Clin North Am 11:875-887
4. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA (1999) Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 282:517-523
5. Kim JY, Lautenbach E, Chu J, Goyal M, Nachamkin I, McGowan K, Coffin S, Zaoutis T (2008) Fluoroquinolone resistance in pediatric bloodstream infections because of Escherichia coli and Klebsiella species. Am J Infect Control 36:70-73
6. Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF (1999) Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut. J Clin Microbiol 37:4065-4070
7. Vranes J, Marijan T, Bedenic B, Mlinaric-Dzepina A, Katic S, Kalenic S (2008) Clonal dissemination of highly virulent extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from the urine of non-hospitalised patients in Zagreb region. Int J Antimicrob Agents 31:19S1-24S1
8. Ena J, Arjona F, Martínez-Peinado C, López-Perezagua Mdel M, Amador C (2006) Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 68:1169-1174
9. Taneja N, Rao P, Arora J, Dogra A (2008) Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI. Indian J Med Res 127:85-88
10. Gaspari RJ, Dickson E, Karlowsky J, Doern G (2005) Antibiotic resistance in paediatric uropathogens. Int J Antimicrob Agents 26:267-271
11. Raymond J, Nordmann P, Doit C, Vu Thien H, Guibert M, Ferroni A, Aujard Y (2007) Multidrug-resistant bacteria in hospitalized children: A 5-year multicenter study. Pediatrics 119:e798-e803
12. Anatoliotaki M, Galanakis E, Schinaki A, Stefanaki S, Mavrokosta M, Tsilimigaki A (2007) Antimicrobial resistance of urinary tract pathogens in children in Crete, Greece. Scand J Infect Dis 39:671-675
13. Yüksel S, Oztürk B, Kavaz A, Ozçakar ZB, Acar B, Güriz H, Aysev D, Ekim M, Yalçinkaya F (2006) Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Int J Antimicrob Agents 28:413-416
14. Lutter SA, Currie ML, Mitz LB, Greenbaum LA (2005) Antibiotic resistance patterns in children hospitalized for urinary tract infections. Arch Pediatr Adolesc Med 159:924-928
15. Prelog M, Schiefecker D, Fille M, Wurzner R, Brunner A, Zimmerhackl LB, Wurzner R, Brunner A, Zimmerhackl LB (2008) Febrile urinary tract infection in children: Ampicillin and trimethoprim insufficient as empirical mono-therapy. Pediatr Nephrol 23:597-602
16. Haller M, Brandis M, Berner R (2004) Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol 19:982-986
17. Zaoutis TE, Goyal M, Chu JH, Coffin SE, Bell LM, Nachamkin I, McGowan KL, Bilker WB, Lautenbach E (2005) Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics 115:942-949
18. Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS (2007) Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 60:629-637
19. Huang SS, Lee MH, Leu HS (2006) Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella. J Microbiol Immunol Infect 39:496-502
20. Kuo KC, Shen YH, Hwang KP (2007) Clinical implications and risk factors of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection in children: A case-control retrospective study in a medical center in southern Taiwan. J Microbiol Immunol Infect 40:248-254
21. Réjiba S, Kechrid A (2007) Patterns of resistance to beta-lactams and characterization of beta-lactamases in Escherichia coli isolates from children in Tunisia. J Chemother 19:382-387
22. Tellevik MG, Sollid JE, Blomberg B, Jureen R, Urassa WK, Langeland N (2007) Extended-spectrum beta-lactamase-type SHV-12-producing Enterobacteriaceae causing septicemia in Tanzanian children: Vectors for horizontal transfer of antimicrobial resistance. Diagn Microbiol Infect Dis 59:351-354
23. Wadula J, von Gottberg A, Kilner D, de Jong G, Cohen C, Khoosal M, Keddy K, Crewe-Brown H (2006) Nosocomial outbreak of extended-spectrum beta-lactamase-producing Salmonella isangi in pediatric wards. Pediatr Infect Dis J 25:843-844
24. Qin X, Zerr DM, Weissman SJ, Englund JA, Denno DM, Klein EJ, Tarr PI, Kwong J, Stapp JR, Tulloch LG, Galanakis E (2008) Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: A children's hospital experience. Antimicrob Agents Chemother 11:3909-39014
25. Delińska-Galińska A, Kurlenda J, Kozielska E, Borkowska A, Luczak G, Plata-Nazar K (2006) Prevalence of ESBL strains in urinary tract infections in children in 1996 and 2004. Przegl Epidemiol 60:59-64
26. Giamarellou H (2005) Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect 11:1S4-16S4
27. Thomson RB Jr (2007) Specimen collection, transport and processing: bacteriology. In: Murray P, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology, vol I, 9th edn. American Society for Microbiology, Washington, pp 291-333
28. Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial suspectibility testing: Nineteenth informational supplement. CLSI Document M100-S19. Wayne, PA, USA. Available at http://www.clsi.org/source/orders/free/m100-s19.pdf
29. Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Möbius TE (1985) International system of radiographic grading of vesicoureteric reflux. International reflux study in children. Pediatr Radiol 15:105-109
30. Christian MT, McColl JH, MacKenzie JR, Tj B (2000) Risk assessment of renal cortical scarring with urinary tract infection by clinical features and ultrasonography. Arch Dis Child 82:376-380
31. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791-797
32. Akram M, Shahid M, Khan AU (2007) Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh. India. Ann Clin Microbiol Antimicrob 6:4
33. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32:1162-1171
34. Calbo E, Romani V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J (2006) Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum b-lactamases. J Antimicrob Chemother 57:780-783
35. Winberg J, Bollgren I, Gothefors L, Herthelius M, Tullus K (1989) The prepuce: A mistake of nature? Lancet 1:598-599
36. Singh-Grewal D, Macdessi J, Craig J (2005) Circumcision for the prevention of urinary tract infection in boys: A systematic review of randomized trials and observational studies. Arch Dis Child 90:853-858
37. Lescure FX, Eveillard M, Douadi Y, Eb F (2001) Community-acquired multiresistant bacteria: An emerging problem? J Hosp Infec 49:149-151
38. Rodriguez-Bano J, Navarro MD, Romero L, Martínez-Martínez L, Muniain MA, Perea EJ, Pérez-Cano R, Pascual A (2004) Epidemiology and clinical features of infections caused by extended-spectrum-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42:1089-1094